Abstract
Circular RNA-based competing endogenous RNA (ceRNA) networks contribute to the initiation and development of various types of cancer, including hepatocellular carcinoma (HCC). Although a novel circular RNA itchy E3 ubiquitin protein ligase (circITCH) is identified as a tumor suppressor in HCC, its detailed molecular mechanisms have not been fully delineated. The present study was designed to resolve this issue, and we firstly verified that circITCH suppressed the malignant phenotypes in HCC cells by regulating a novel miR-421/B-cell translocation gene 1 (BTG1) axis. Specifically, through performing the Real-Time qPCR analysis, we noticed that circITCH expression in HCC tumor tissues or cell lines were significantly lower than that in adjacent normal tissues or normal hepatocytes, and the expression levels of circITCH were negatively correlated with tumor size and TNM stage in HCC patients. Next, our functional experiments confirmed that overexpression of circITCH induced cell cycle arrest and apoptosis, and reduced cell viability and colony forming ability in Hep3B and Huh7 cells. Mechanically, bioinformatics analysis, RNA immunoprecipitation and luciferase reporter assay demonstrated that circITCH served as RNA sponges for miR-421 to elevate BTG1 levels in HCC cells. The rescuing experiments verified that upregulation of miR-421 promoted cell viability and colony formation, and reduced apoptosis, which were abrogated by overexpression of circITCH or BTG1. In conclusion, this study identified a novel circITCH/miR-421/BTG1 axis that restrained the development of HCC, and our findings provided novel biomarkers for the treatment of this disease.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data were all included in this manuscript. The original data are available from the corresponding author upon reasonable request.
References
Arellano M, Moreno S (1997) Regulation of CDK/cyclin complexes during the cell cycle. Int J Biochem Cell Biol 29:559–573. https://doi.org/10.1016/s1357-2725(96)00178-1
Bai S, Wu Y, Yan Y, Shao S, Zhang J, Liu J, Hui B, Liu R, Ma H, Zhang X et al (2020) Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma. Sci Rep 10:13659. https://doi.org/10.1038/s41598-020-70484-2
Cao L, Chen F, Yang X, Xu W, Xie J, Yu L (2014) Phylogenetic analysis of CDK and cyclin proteins in premetazoan lineages. BMC Evol Biol. https://doi.org/10.1186/1471-2148-14-10
Chen RX, Liu HL, Yang LL, Kang FH, Xin LP, Huang LR, Guo QF, Wang YL (2019) Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. Eur Rev Med Pharmacol Sci 23:8771–8778. https://doi.org/10.26355/eurrev_201910_19271
Chidambaranathan-Reghupaty S, Fisher PB, Sarkar D (2021) Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv Cancer Res. https://doi.org/10.1016/bs.acr.2020.10.001
Forner A, Reig M, Bruix J (2018) Hepatocellular carcinoma. Lancet 391:1301–1314. https://doi.org/10.1016/s0140-6736(18)30010-2
Gabriel AF, Costa MC, Enguita FJ (2020) Circular RNA-centered regulatory networks in the physiopathology of cardiovascular diseases. Int J Mol Sci. https://doi.org/10.3390/ijms21020456
Gao P, Huang Y, Hou Y, Li Q, Wang H (2021) Circular RNA ITCH is a tumor suppressor in clear cell renal cell carcinoma metastasis through miR-106b-5p/PDCD4 axis. J Immunol Res. https://doi.org/10.1155/2021/5524344
Gongpan P, Lu Y, Wang F, Xu Y, Xiong W (2016) AS160 controls eukaryotic cell cycle and proliferation by regulating the CDK inhibitor p21. Cell Cycle 15:1733–1741. https://doi.org/10.1080/15384101.2016.1183853
Guo W, Zhang J, Zhang D, Cao S, Li G, Zhang S, Wang Z, Wen P, Yang H, Shi X et al (2017) Polymorphisms and expression pattern of circular RNA circ-ITCH contributes to the carcinogenesis of hepatocellular carcinoma. Oncotarget. 8:48169–48177. https://doi.org/10.18632/oncotarget.18327
Guo Y, Zheng H, Yin J, Wang H (2021) Rs4911154 of circ-ITCH aggravated tumor malignancy of thyroid nodules via the circ-ITCH/miR-22-3p/CBL axis. Sci Rep 11:18491. https://doi.org/10.1038/s41598-021-97471-5
Huang G, Liang M, Liu H, Huang J, Li P, Wang C, Zhang Y, Lin Y, Jiang X (2020) CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway. Cell Death Dis 11:1065. https://doi.org/10.1038/s41419-020-03276-1
Hui Y, Jin D, Leng J, Liu D, Yuan P, Tang C, Wang Q (2022) Hsa_circ_0007059 sponges miR-421 to repress cell growth and stemness in hepatocellular carcinoma by the PTEN-AKT/mTOR pathway. Pathol Res Pract. https://doi.org/10.1016/j.prp.2021.153692
Ishola AA, Chien CS, Yang YP, Chien Y, Yarmishyn AA, Tsai PH, Chen JC, Hsu PK, Luo YH, Chen YM et al (2022) Oncogenic circRNA C190 promotes non-small cell lung cancer via modulation of the EGFR/ERK pathway. Cancer Res 82:75–89. https://doi.org/10.1158/0008-5472.Can-21-1473
John PC, Mews M, Moore R (2001) Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division. Protoplasma 216:119–142. https://doi.org/10.1007/bf02673865
Kanda M, Sugimoto H, Nomoto S, Oya H, Hibino S, Shimizu D, Takami H, Hashimoto R, Okamura Y, Yamada S et al (2015) B-cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma. Int J Oncol 46:641–648. https://doi.org/10.3892/ijo.2014.2762
Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J (2019) The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 20:675–691. https://doi.org/10.1038/s41576-019-0158-7
Li F, Zhang L, Li W, Deng J, Zheng J, An M, Lu J, Zhou Y (2015) Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget 6:6001–6013. https://doi.org/10.18632/oncotarget.3469
Li K, Tang J, Hou Y (2019) LncRNA GATA6-AS inhibits cancer cell migration and invasion in gallbladder cancer by downregulating miR-421. Onco Targets Ther. https://doi.org/10.2147/ott.S212231
Li J, Guo R, Liu Q, Sun J, Wang H (2020a) Circular RNA circ-ITCH inhibits the malignant behaviors of cervical cancer by microRNA-93-5p/FOXK2 axis. Reprod Sci 27:860–868. https://doi.org/10.1007/s43032-020-00140-7
Li Y, Ge YZ, Xu L, Jia R (2020) Circular RNA ITCH: a novel tumor suppressor in multiple cancers. Life Sci. https://doi.org/10.1016/j.lfs.2019.117176
Li Y, Huo J, He J, Zhang Y, Ma X (2020) BTG1 inhibits malignancy as a novel prognosis signature in endometrial carcinoma. Cancer Cell Int. https://doi.org/10.1186/s12935-020-01591-3
Liang H, Huang H, Li Y, Lu Y, Ye T (2020) CircRNA_0058063 functions as a ceRNA in bladder cancer progression via targeting miR-486-3p/FOXP4 axis. Biosci Rep. https://doi.org/10.1042/bsr20193484
Lin A, Wang G, Zhao H, Zhang Y, Han Q, Zhang C, Tian Z, Zhang J (2016) TLR4 signaling promotes a COX-2/PGE(2)/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells. Oncoimmunology. 5:e1074376. https://doi.org/10.1080/2162402x.2015.1074376
Lin Q, Jiang H, Lin D (2021) Circular RNA ITCH downregulates GLUT1 and suppresses glucose uptake in melanoma to inhibit cancer cell proliferation. J Dermatolog Treat 32:231–235. https://doi.org/10.1080/09546634.2019.1654069
Liu J, Xue N, Guo Y, Niu K, Gao L, Zhang S, Gu H, Wang X, Zhao D, Fan R (2019) CircRNA_100367 regulated the radiation sensitivity of esophageal squamous cell carcinomas through miR-217/Wnt3 pathway. Aging (Albany NY) 11:12412–12427. https://doi.org/10.18632/aging.102580
Lu YF, Sun GG, Liu Q, Yang CR, Cheng YJ (2014) BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker. Int J Oncol 45:1574–1582. https://doi.org/10.3892/ijo.2014.2543
Ma J, Zhao G, Du J, Li J, Lin G, Zhang J (2021) LncRNA FENDRR inhibits gastric cancer cell proliferation and invasion via the miR-421/SIRT3/Notch-1 axis. Cancer Manag Res. https://doi.org/10.2147/cmar.S329419
Marks EI, Yee NS (2016) Molecular genetics and targeted therapy in hepatocellular carcinoma. Curr Cancer Drug Targets 16:53–70. https://doi.org/10.2174/1568009615666150916092903
Mo XM, Qin PF, Wang B, Liu FH, Li HH (2020) miR-421 promotes the viability of A549 lung cancer cells by targeting forkhead box O1. Oncol Lett 20:306. https://doi.org/10.3892/ol.2020.12169
Nan YH, Wang J, Wang Y, Sun PH, Han YP, Fan L, Wang KC, Shen FJ, Wang WH (2016) MiR-4295 promotes cell growth in bladder cancer by targeting BTG1. Am J Transl Res 8:4892–4901
Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S et al (2017) Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 11(4):317–370. https://doi.org/10.1007/s12072-017-9799-9
Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS (2016) Future of hepatocellular carcinoma incidence in the United States forecast through 2030. J Clin Oncol 34:1787–1794. https://doi.org/10.1200/jco.2015.64.7412
Pinyol R, Torrecilla S, Wang H, Montironi C, Piqué-Gili M, Torres-Martin M, Wei-Qiang L, Willoughby CE, Ramadori P, Andreu-Oller C et al (2021) Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 75:865–878. https://doi.org/10.1016/j.jhep.2021.04.049
Rossi F, Centrón-Broco A, Dattilo D, Di Timoteo G, Guarnacci M, Colantoni A, Beltran Nebot M, Bozzoni I (2021) CircVAMP3: a circRNA with a role in alveolar rhabdomyosarcoma cell cycle progression. Genes (Basel). https://doi.org/10.3390/genes12070985
Salamina M, Montefiore BC, Liu M, Wood DJ, Heath R, Ault JR, Wang LZ, Korolchuk S, Baslé A, Pastok MW et al (2021) Discriminative SKP2 interactions with CDK-cyclin complexes support a cyclin A-specific role in p27KIP1 degradation. J Mol Biol 433:166795. https://doi.org/10.1016/j.jmb.2020.166795
Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30. https://doi.org/10.3322/caac.21590
Su Y, Lv X, Yin W, Zhou L, Hu Y, Zhou A, Qi F (2019) CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression. Aging (Albany NY) 11:8183–8203. https://doi.org/10.18632/aging.102312
Sun GG, Wang YD, Cheng YJ, Hu WN (2014) BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma. Tumour Biol 35:9707–9716. https://doi.org/10.1007/s13277-014-2245-x
Wang Y, Mo Y, Gong Z, Yang X, Yang M, Zhang S, Xiong F, Xiang B, Zhou M, Liao Q et al (2017) Circular RNAs in human cancer. Mol Cancer 16:25. https://doi.org/10.1186/s12943-017-0598-7
Wang M, Chen B, Ru Z, Cong L (2018) CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway. Biochem Biophys Res Commun 504:283–288. https://doi.org/10.1016/j.bbrc.2018.08.175
Wang ST, Liu LB, Li XM, Wang YF, Xie PJ, Li Q, Wang R, Wei Q, Kang YH, Meng R et al (2019a) Circ-ITCH regulates triple-negative breast cancer progression through the Wnt/β-catenin pathway. Neoplasma 66:232–239. https://doi.org/10.4149/neo_2018_180710N460
Wang X, Wang R, Wu Z, Bai P (2019) Circular RNA ITCH suppressed prostate cancer progression by increasing HOXB13 expression via spongy miR-17–5p. Cancer Cell Int. https://doi.org/10.1186/s12935-019-0994-8
Wang J, Zhao X, Wang Y, Ren F, Sun D, Yan Y, Kong X, Bu J, Liu M, Xu S (2020a) circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma. Cell Death Dis 11:32. https://doi.org/10.1038/s41419-020-2230-9
Wang W, Li Y, Li X, Liu B, Han S, Li X, Zhang B, Li J, Sun S (2020) Circular RNA circ-FOXP1 induced by SOX9 promotes hepatocellular carcinoma progression via sponging miR-875–3p and miR-421. Biomed Pharmacother. https://doi.org/10.1016/j.biopha.2019.109517
Wang Y, Yao R, Zhang D, Chen R, Ren Z, Zhang L (2020c) Circulating neutrophils predict poor survival for HCC and promote HCC progression through p53 and STAT3 signaling pathway. J Cancer 11:3736–3744. https://doi.org/10.7150/jca.42953
Xie Y, Wang Y, Xue W, Zou H, Li K, Liu K, Zhao W, Zhu C, Cao J (2021) Profiling and integrated analysis of differentially expressed microRNAs as novel biomarkers of hepatocellular carcinoma. Front Oncol. https://doi.org/10.3389/fonc.2021.770918
Xu F, Zha G, Wu Y, Cai W, Ao J (2018) Overexpressing lncRNA SNHG16 inhibited HCC proliferation and chemoresistance by functionally sponging hsa-miR-93. Onco Targets Ther. https://doi.org/10.2147/ott.S182005
Xu L, Feng X, Hao X, Wang P, Zhang Y, Zheng X, Li L, Ren S, Zhang M, Xu M (2019) CircSETD3 (Hsa_circ_0000567) acts as a sponge for microRNA-421 inhibiting hepatocellular carcinoma growth. J Exp Clin Cancer Res 38:98. https://doi.org/10.1186/s13046-019-1041-2
Xue K, Wu JC, Li XY, Li R, Zhang QL, Chang JJ, Liu YZ, Xu CH, Zhang JY, Sun XJ et al (2021) Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma. Cell Death Dis 12:900. https://doi.org/10.1038/s41419-021-04187-5
Yan H, Xiang H, Sun B, Feng F, Chen P (2020) Circular RNA-ITCH inhibits the proliferation of ovarian carcinoma by downregulating lncRNA HULC. Reprod Sci 27:375–379. https://doi.org/10.1007/s43032-019-00049-w
Zeng Z, Zhou W, Duan L, Zhang J, Lu X, Jin L, Yu Y (2019) Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway. J Cell Physiol 234:3887–3896. https://doi.org/10.1002/jcp.27162
Zeng X, Yuan X, Cai Q, Tang C, Gao J (2021) Circular RNA as an epigenetic regulator in chronic liver diseases. Cells. https://doi.org/10.3390/cells10081945
Zhang SQ, Yang Z, Cai XL, Zhao M, Sun MM, Li J, Feng GX, Feng JY, Ye LH, Niu JQ et al (2017) miR-511 promotes the proliferation of human hepatoma cells by targeting the 3’UTR of B cell translocation gene 1 (BTG1) mRNA. Acta Pharmacol Sin 38:1161–1170. https://doi.org/10.1038/aps.2017.62
Zhang Y, Ke X, Liu J, Ma X, Liu Y, Liang D, Wang L, Guo C, Luo Y (2019) Characterization of circRNA-associated ceRNA networks in patients with nonvalvular persistent atrial fibrillation. Mol Med Rep 19:638–650. https://doi.org/10.3892/mmr.2018.9695
Zhang L, Tao H, Li J, Zhang E, Liang H, Zhang B (2021) Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma. Aging (Albany NY) 13:15990–16008. https://doi.org/10.18632/aging.203056
Zhang N, Zhang X, Xu W, Zhang X, Mu Z (2021b) CircRNA_103948 inhibits autophagy in colorectal cancer in a ceRNA manner. Ann N Y Acad Sci 1503:88–101. https://doi.org/10.1111/nyas.14679
Zhang S, Sun J, Gu M, Wang G, Wang X (2021c) Circular RNA: a promising new star for the diagnosis and treatment of colorectal cancer. Cancer Med 10:8725–8740. https://doi.org/10.1002/cam4.4398
Zhang J, Cai Y, Sheng S, Zhao C, Jiang B (2022a) circITCH suppresses cell proliferation and metastasis through miR-660/TFCP2 pathway in melanoma. Cancer Med 11:2405–2413. https://doi.org/10.1002/cam4.4627
Zhang P, Yang X, Zha Z, Zhu Y, Zhang G, Li G (2022b) CBX3 regulated by miR-139 promotes the development of HCC by regulating cell cycle progression. Cell Cycle 21:1740–1752. https://doi.org/10.1080/15384101.2022.2068329
Zhao LM, Pang AX (2017) Iodine-131 treatment of thyroid cancer cells leads to suppression of cell proliferation followed by induction of cell apoptosis and cell cycle arrest by regulation of B-cell translocation gene 2-mediated JNK/NF-κB pathways. Braz J Med Biol Res 50:e5933. https://doi.org/10.1590/1414-431x20165933
Zhu R, Zou ST, Wan JM, Li W, Li XL, Zhu W (2013) BTG1 inhibits breast cancer cell growth through induction of cell cycle arrest and apoptosis. Oncol Rep 30:2137–2144. https://doi.org/10.3892/or.2013.2697
Zhu R, Li W, Xu Y, Wan J, Zhang Z (2015) Upregulation of BTG1 enhances the radiation sensitivity of human breast cancer in vitro and in vivo. Oncol Rep 34:3017–3024. https://doi.org/10.3892/or.2015.4311
Author information
Authors and Affiliations
Contributions
All the authors contributed equal work in this research.
Corresponding author
Ethics declarations
Conflict of interest
The authors declared no conflict of interest in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, X., Yin, X., Bao, H. et al. Targeting a novel circITCH/miR-421/BTG1 axis is effective to suppress the malignant phenotypes in hepatocellular carcinoma (HCC) cells. Cytotechnology 75, 255–267 (2023). https://doi.org/10.1007/s10616-023-00576-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-023-00576-0